Sort   by:  
 Page size 
UnknownProportion of alemtuzumab-treated patients converting from relapsing-remitting multiple sclerosis to secondary progressive multiple sclerosis over 6 years.
Not available
S-EPMC7750777 | biostudies-literature
UnknownEfficacy and safety of alemtuzumab over 6 years: final results of the 4-year CARE-MS extension trial.
Not available
S-EPMC8072102 | biostudies-literature
UnknownIdentifying P300 brain-computer interface training strategies for AAC in children: a focus group study.
Not available
S-EPMC12435780 | biostudies-literature
UnknownAI-Enhanced 3D Models in Global Virtual Reality Case Conferences for Surgical Care in a Low-Income Country: Exploratory Study.
Not available
S-EPMC12360718 | biostudies-literature
UnknownLoss of glymphatic homeostasis in heart failure.
Not available
S-EPMC11884761 | biostudies-literature
UnknownThe Immunology Game: A Board Game to Enhance Medical Immunology Education.
Not available
S-EPMC12549956 | biostudies-literature
UnknownAutoimmunity and long-term safety and efficacy of alemtuzumab for multiple sclerosis: Benefit/risk following review of trial and post-marketing data.
Not available
S-EPMC8978465 | biostudies-literature
UnknownComparative Effectiveness Research of Disease-Modifying Therapies for the Management of Multiple Sclerosis: Analysis of a Large Health Insurance Claims Database.
Not available
S-EPMC5447557 | biostudies-literature
UnknownA network model of glymphatic flow under different experimentally-motivated parametric scenarios.
Not available
S-EPMC9062681 | biostudies-literature
UnknownOral ponesimod in relapsing-remitting multiple sclerosis: a randomised phase II trial.
Not available
S-EPMC4215282 | biostudies-literature
Sort   by:  
 Page size